Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2007 Jan 20;13(2):164–171. doi: 10.1016/j.bbmt.2006.10.031

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

MLR results. Shown are averages of 6 experiments, with each individual experiment done in triplicate. Anti-CD154 mAb 5c8, irrelevant mAb 31A (negative control), and CTLA4-Ig (positive control) were added at concentrations of 10 μg/mL each. The maximum ³H-thymidine uptake of the medium control in each experiment was set at 100%. Error bars represent 1 standard deviation. P values were calculated using the paired Student t test. Medium versus irrelevant mAb 31A, P = .14; medium versus 5c8, P < .0001; medium versus CTLA4Ig, P < .0001; mAb 5c8 versus CTLA4Ig, P = .04.